Abrdn PLC Adaptive Biotechnologies Corp Transaction History
Abrdn PLC
- $51.7 Billion
- Q4 2024
A detailed history of Abrdn PLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Abrdn PLC holds 1,004,059 shares of ADPT stock, worth $8.16 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,004,059
Previous 1,029,447
2.47%
Holding current value
$8.16 Million
Previous $5.27 Million
14.31%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ADPT
# of Institutions
205Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$244 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$117 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$94.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$94.3 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$86.5 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.16B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...